Progentec Gains Additional Funding for Lupus Detection and Management Platforms

By sarah | News | 0 comment | 8 December, 2018 | 0

By Mary Chapman
Lupus News Today
Copyright © 2013-2018 All rights reserved.

Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity.

Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2E and OCA Ventures, with participation by global healthcare provider NMC Lifesciences. Using technology created by the Oklahoma Medical Research Foundation, the platform is touted as being able to detect impending flares and track underlying disease movement.

“Today’s funding round is the next step on our journey to making this and other advanced tools commercially available to patients with lupus, a disease that afflicts more than one million Americans, many of whom are women,” Mohan Purushothaman, PhD, Progentec’s CEO, said in a press release. “The Progentec tests will become powerful tools to help patients and healthcare providers stay ahead of lupus.”

Read the entire story at Lupus News Today

Lupus News Today, Mohan Purushothaman, Progentec Diagnostics

i2E investment an important validation of technology developed by OKC’s Progentec Diagnostics

By sarah | 0 comment

By Scott Meacham As i2E has been closing our latest round of new investments over the last few weeks, I am reminded of how in the startup world and the venture industry, investment events attractRead more
OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients

By sarah | 0 comment

By Scott Meacham Lupus is chronic autoimmune condition with devastating effects. The disease is difficult to diagnose. Its course is unpredictable. There is no cure and few FDA-approved medications. Patients who have lupus live withRead more
OKC-based Progentec Diagnostics refines test to predict future lupus flares

By sarah | 0 comment

By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still anotherRead more
Progentec Diagnostics Raises Funds to Support Advances in Lupus Detection and Management

By sarah | 0 comment

– New funding brings lupus-detection tools closer to commercialization – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), aRead more
Oklahoma Medical Research Foundation a valuable contributor medically — and economically

By sarah | 0 comment

By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identifyRead more

Cancel reply

Next Previous

Progentec Gains Additional Funding for Lupus Detection and Management Platforms

Progentec Gains Additional Funding for Lupus Detection and Management Platforms

Related Posts

i2E investment an important validation of technology developed by OKC’s Progentec Diagnostics

OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients

OKC-based Progentec Diagnostics refines test to predict future lupus flares

Progentec Diagnostics Raises Funds to Support Advances in Lupus Detection and Management

Oklahoma Medical Research Foundation a valuable contributor medically — and economically

Leave a Comment

Cancel reply

Oklahoma City Office

Tulsa Office